Search Results 421-430 of 18868 for what is vedolizumab

1. Immuno-Epigenetics: William A. Faubion Jr.

   ... Crohn's disease and ulcerative colitis. Epigenetics is the study of the heritable changes to gene expression without changing the DNA code. Environmental ...

2. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.

3. Is a hepatitis B immunity check needed for IBD patients? - Mayo Clinic News Network

   Treatment guidelines call for patients newly diagnosed with IBD (Crohn's disease and ulcerative colitis) to delay treatment until they can be screened for ...

4. Talha A. Malik, M.D. - Doctors and Medical Staff - Mayo Clinic

   He is American Board Certified in Gastroenterology with specialty interest and fellowship training in Crohn's disease and ulcerative colitis, the two main ...

5. IBS Archives - Mayo Clinic News Network

   ... Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early ...

6. A Study to Evaluate the Long-Term Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis (UC) - Mayo Clinic

   This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis (UC) who have not responded at the end ...

7. Ileoanal anastomosis (J-pouch) surgery - Doctors & Departments - Mayo Clinic

   This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

8. Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease - Mayo Clinic

   The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease. The study will test ...

9. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis ... approved biologic agent ( ...

10. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER). Print ...